TY - JOUR
T1 - Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer
AU - Jones, Desiree
AU - Zhao, Fengmin
AU - Brell, Joanna
AU - Lewis, Mark A.
AU - Loprinzi, Charles L.
AU - Weiss, Matthias
AU - Fisch, Michael J.
N1 - Funding Information:
This study was supported in part by Public Health Service Grants CA37604, CA17145, and grants from the National Cancer Institute, National Institutes of Health and the Department of Health and Human Services. Drs. Fisch and Zhao had full access to the data.
Publisher Copyright:
© 2014, Springer Science+Business Media New York.
PY - 2015/2/26
Y1 - 2015/2/26
N2 - Purpose: We investigated how treatment-induced neuropathic symptoms are associated with patients’ quality of life (QOL) and clinician-reported difficulty in caring for patients. Methods: Data were obtained from 3,106 outpatients with colorectal, breast, lung, or prostate cancer on numbness/tingling (N/T), neuropathic pain, and QOL. Clinicians reported the degree of difficulty in caring for patients’ physical and psychological symptoms. Results: For all patients, moderate to severe N/T was associated with poor QOL (OR = 1.82, 95 % CI = 1.47–2.26, P < 0.001) but neuropathic pain was not (OR = 1.31, 95 % CI = 0.94–1.83, P = 0.114). Moderate to severe N/T and neuropathic pain were associated with increased care difficulty (OR = 1.49, 95 % CI = 1.27–1.74, P < 0.001 for N/T, and OR = 1.46, 95 % CI = 1.15–1.84, P = 0.002 for neuropathic pain). The association of neuropathic pain with care difficulty was most significant in patients with colorectal cancer (CRC) (OR = 2.32, 95 % CI = 1.41–3.83, P = 0.001). Baseline neuropathic pain was associated with declining QOL in CRC patients (OR = 2.08, 95 % CI = 1.21–3.58, P = 0.008). Conclusions: Clinicians may experience increased care difficulty for patients of all cancer types with moderate to severe N/T or neuropathic pain; care difficulty due to neuropathic pain may be higher for CRC patients. Nearly half the patients of all cancer types with moderate to severe N/T may expect poor short-term QOL; CRC—but not other—patients with baseline neuropathic pain are likely to experience declining QOL. Implications for Cancer Survivors: About half of patients with moderate to severe N/T (any cancer type) may expect poor QOL in the short term; CRC patients with baseline neuropathic pain in particular may experience declining QOL.
AB - Purpose: We investigated how treatment-induced neuropathic symptoms are associated with patients’ quality of life (QOL) and clinician-reported difficulty in caring for patients. Methods: Data were obtained from 3,106 outpatients with colorectal, breast, lung, or prostate cancer on numbness/tingling (N/T), neuropathic pain, and QOL. Clinicians reported the degree of difficulty in caring for patients’ physical and psychological symptoms. Results: For all patients, moderate to severe N/T was associated with poor QOL (OR = 1.82, 95 % CI = 1.47–2.26, P < 0.001) but neuropathic pain was not (OR = 1.31, 95 % CI = 0.94–1.83, P = 0.114). Moderate to severe N/T and neuropathic pain were associated with increased care difficulty (OR = 1.49, 95 % CI = 1.27–1.74, P < 0.001 for N/T, and OR = 1.46, 95 % CI = 1.15–1.84, P = 0.002 for neuropathic pain). The association of neuropathic pain with care difficulty was most significant in patients with colorectal cancer (CRC) (OR = 2.32, 95 % CI = 1.41–3.83, P = 0.001). Baseline neuropathic pain was associated with declining QOL in CRC patients (OR = 2.08, 95 % CI = 1.21–3.58, P = 0.008). Conclusions: Clinicians may experience increased care difficulty for patients of all cancer types with moderate to severe N/T or neuropathic pain; care difficulty due to neuropathic pain may be higher for CRC patients. Nearly half the patients of all cancer types with moderate to severe N/T may expect poor short-term QOL; CRC—but not other—patients with baseline neuropathic pain are likely to experience declining QOL. Implications for Cancer Survivors: About half of patients with moderate to severe N/T (any cancer type) may expect poor QOL in the short term; CRC patients with baseline neuropathic pain in particular may experience declining QOL.
KW - Colorectal cancer
KW - Neuropathic pain
KW - Neuropathy
KW - Numbness/tingling
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=84931956176&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84931956176&partnerID=8YFLogxK
U2 - 10.1007/s11764-014-0379-x
DO - 10.1007/s11764-014-0379-x
M3 - Article
C2 - 25023039
AN - SCOPUS:84931956176
VL - 9
SP - 1
EP - 10
JO - Journal of Cancer Survivorship
JF - Journal of Cancer Survivorship
SN - 1932-2259
IS - 1
ER -